FDA Approves Baloxavir Marboxil for ANDA217449
The FDA has approved Baloxavir Marboxil under ANDA217449 submitted by Norwich.
Asset / Drug
Drug and asset intelligence for Norwich with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.